Semaglutide is commonly used to treat type 2 diabetes and aid weight loss, but scientists are also exploring how this GLP-1 receptor agonist can treat other health conditions, including heart failure
You have to sign up for a year
After that, you need a refresh
Some studies show that human growth hormone (hGH) can potentially treat obesity
The problem, then, was to engineer analogs that could resist proteolysis by DPP-4 while maintaining or enhancing the receptor-activation properties of the natural hormone
They suggest that future studies should investigate how cumulative drug exposure, peak drug concentrations, and treatment adherence contribute to cardiovascular protection, as well as whether GLP-1 signaling in cardiac and epicardial adipose tissues plays a direct role